Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04853017
Title A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumor (AMPLIFY-201)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Elicio Therapeutics
Indications

pancreatic ductal adenocarcinoma

Advanced Solid Tumor

Therapies

ELI-002

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Recruiting Duarte California 91010 United States Details
University of California Los Angeles Recruiting Los Angeles California 90095 United States Details
University of Colorado Recruiting Aurora Colorado 80045 United States Details
University of Iowa Recruiting Iowa City Iowa 52242 United States Details
Massachusetts General Hospital Recruiting Boston Massachusetts 02114 United States Details
Henry Ford Cancer Institute Withdrawn Detroit Michigan 48202 United States Details
Washington University School of Medicine Active, not recruiting Saint Louis Missouri 63110 United States Details
Northwell Health Recruiting Lake Success New York 11042 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Tennessee Oncology - Centennial Clinic Active, not recruiting Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field